Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3266504 | Digestive and Liver Disease | 2006 | 4 Pages |
Abstract
This brief review appraises the current evidence of the efficacy of probiotics, including lactobacilli, bifidobacteria, and VSL#3, in the treatment of irritable bowel syndrome (IBS). The mechanisms potentially important will be evaluated, with specific reference to immune function, effects on motility and intraluminal milieu. These experimental and clinical observations suggest that probiotics may play a role in the management of IBS.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism